Summary
To explore the initial steps by which transplanted MSCs interact with the vessel wall in the course of extravasation, we studied binding of human MSCs to endothelial cells (ECs). In a parallel plate flow chamber, MSCs bound to human umbilical vein ECs (HUVECs) similar to peripheral blood mononuclear cells (PBMC) or CD34 + hematopoietic progenitors at shear stresses of up to 2 dynes/cm². This involved rapid extension of podia, rolling, and subsequent firm adhesion which was increased when ECs were pre-stimulated with TNF-α. MSC binding was suppressed when ECs were pretreated with function-blocking anti-P-selectin antibody, and rolling of MSCs was induced on immobilized P-selectin, indicating that P-selectin was involved in this 
Introduction
In recent years, mesenchymal stem cells (MSCs) have been characterized as adherent cell populations originating from bone marrow, capable to expand in vitro as undifferentiated cells or to differentiate into osteocytes, chondrocytes, tenocytes, adipocytes or smooth muscle cells [1] [2] [3] . MSCs have been used in a number of preclinical models to mediate the regeneration of muscle, endothelial, neuronal, skin or renal epithelial tissue [4] [5] [6] [7] .
In vitro differentiation studies have demonstrated the potential of MSCs to also form alveolar and airway epithelial cells or cardiac pacemaker cells 8, 9 . Moreover, MSCs have been transplanted intravenously and
shown to distribute to spleen, bone, lung and cartilage in several rodent models [10] [11] [12] .
Intravenously injected MSCs have already been used in patients in order to accelerate hematopoietic reconstitution after hematopoietic stem cell transplantation, to overcome the molecular defect in children with osteogenesis imperfecta, or to alleviate the outcome after myocardial infarction [13] [14] [15] [16] [17] .
Transplantation experiments in mice and primates have shown that intravenously applied MSCs distribute to several tissues, and may accumulate in the lungs 10, 12, 18, 19 .
However, currently it is poorly understood to which degree MSCs use specific adhesion mechanisms for egress from the bloodstream, and whether they home in a tissue-specific manner. To leave the bloodstream, mature leukocytes and hematopoietic progenitor cells have been shown to undergo a coordinated sequence of adhesion steps, initiated by tethering events which are mainly mediated by selectins and their ligands 20, 21 . Subsequently, the captured cells roll and encounter chemokines, which eventually activate integrins, resulting in firm arrest and subsequent transendothelial migration.
To elucidate the potential of MSCs to undergo coordinated steps of interaction with ECs, we investigated human MSCs under shear flow using a parallel plate flow chamber, and by intravital microscopy in mice. We show here that human MSCs home to different tissues, and display coordinated rolling and adhesion behaviour on
ECs. Although P-selectin glycoprotein ligand (PSGL)-1 is not expressed by MSCs, MSCs bind to endothelial cells in a P-selectin dependent manner in vitro and in vivo. 
Materials and Methods
Isolation and characterization of cells. Bone marrow samples were obtained from patients undergoing hip joint replacement after informed consent. Ten to 30 ml of aspirate from the femur cavity was anticoagulated with 500 IU/ml heparin. The light density mononuclear cell fraction was prepared by density gradient centrifugation ( were stored analogously and kept at no agitation for the period of the assay.
Detection of mRNA transcripts for adhesion molecules was performed by RT-PCR.
Total RNA was extracted from MSCs using Trizol (Invitrogen, Karlsruhe, Germany).
RNA integrity was checked by gel electrophoresis, and 1 µg RNA of intact samples was reverse transcribed by using the Omniscript Reverse Transcription Kit (Qiagen, Hilden, Germany) at 42°C for 50 min. PCR amplification of the resulting cDNA was performed by using the Taq PCR core kit (Qiagen, Hilden, Germany). Primers . For homing assays, 1x10 6 MSCs were injected into the tail veins of NOD/SCID mice pre-irradiated with 2.5 Gy γ-rays. predominantly in blood and lungs at 2h and 6h, and, at decreasing levels, at 24h post transplantation ( Fig. 2 A, (Fig. 5A) . Moreover, MSCs also rolled on immobilized P-selectin (Fig. 5B) .
Interaction of MSCs with P-selectin was dependent on the presence of divalent cations, since the numbers of rolling cells decreased to 44 MSCs may bind to P-selectin using a ligand that contains fucose and sialic acid residues, but which is different from PSGL-1. HUVECs by both a P-selectin and a VLA-4-dependent mechanism (Fig. 5D) . The simultaneous blockade of P-selectin on ECs and of either VCAM-1 on ECs or of VLA-4 on MSCs did not result in a further decrease of MSC adhesion (Fig. 5D ). These data indicate that binding via both P-selectin and VLA-4/VCAM-1 are both equally required for binding of MSCs to HUVECs, and that P-selectin and VCAM-1/VLA-4 act on different steps of the rolling and adhesion process.
MSCs roll and adhere on the vessel wall in vivo. Finally, to investigate whether MSCs roll and adhere to ECs in vivo, intravital microscopy was applied in a murine model only.
For (Fig. 6A,B) . In addition, MSCs also adhered firmly for short periods in some vessels. When MSCs were analyzed under the same conditions in P-selectin -/-mice, the number of rolling events was significantly reduced compared to analysis in wild-type mice (Fig. 6B) , demonstrating the involvement of P-selectin in this process. Together, these data indicate that MSCs are capable of coordinated rolling and adhesion behavior on ECs, both in vitro and in vivo.
only.
For For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From mediate binding to E-selectin of hematopoietic progenitors 35, 36 . Although MSCs expressed CD44, we found that pre-treatment of HUVECs by function-blocking anti-
E-selectin antibody did not suppress binding of MSCs to ECs (B.R. and R.H., unpublished data). L-selectin was expressed in MSCs, as assessed by RT-PCR.
However, numbers of MSCs expressing L-selectin on the cell surface were low, and we did not observe increased expression of L-selectin after administration of shear force as observed with CXCR4. This indicates that L-selectin is also unlikely to serve as a major adhesion molecule in the MSCs. Thus, the main selectin ligand(s) on MSCs remains to be determined.
We found expression of the β 1 type integrin receptors VLA-4 and VLA-5 on MSCs, similarly as described by Bruder et al. 37 . We have used an intravital microscopy system to directly observe transplanted MSCs after intra-arterial injection. When focusing on postcapillary venules of mice constitutively expressing P-selectin 44, 45 , fluorescence-labeled MSCs were readily seen to move within the blood flow. The numbers of rolling cells correspond to our previous findings using freshly isolated human peripheral blood mononuclear cells 46, 47 . We confirmed our in vitro observations of MSC-EC interactions, shown to depend on P-selectin in vitro, by the use of P-selectin-deficient mice 28 . These results also confirm the coordinated rolling and adhesion behavior of the MSCs observed on ECs, which includes induction by TNF-α and binding via P-selectin, in an in vivo situation. MSCs used for these experiments were from passages 6 or 7.
For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From HUVEC monolayers were pre-treated with 10 ng/ml TNF-α for 4-6 h prior to the experiments. MSCs used for the experiments were derived from passages 6 to 9.
Values are means + SD; n=3. 
MSCs
A B a n t i -P -s e l e c t i n
MSCs MSCs
c o n t r o l a n t i -P S G L -1 
MSCs
MSCs MSCs
c o n t r o l a n t i -P S G L -1 No. of adherent cells a n t i -V C A M -1 + a n t i -P -s e l e c t i n a n t i -V L A -4 + a n t i -P -s e l e c t i n a n t i -V C A M -1 a n t i -V L A -4 a n t i -P -s e l e c t i n No. of adherent cells a n t i -V C A M -1 + a n t i -P -s e l e c t i n a n t i -V L A -4 + a n t i -P -s e l e c t i n a n t i -V C A M -1 a n t i -V L A -4 a n t i -P -s e l e c t i n No. of adherent cells a n t i -V C A M -1 + a n t i -P -s e l e c t i n a n t i -V L A -4 + a n t i -P -s e l e c t i n a n t i -V C A M -1 a n t i -V L A -4 a n t i -P -s e l e c t i n only.
For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From
